Can you customize the product?

Yes, we offer OEM services with customization options from samples and designs.

What are the payment terms?

We accept T/T, D/P, PayPal, Western Union, and small-amount payments.

What is the lead time for production?

The lead time is one month for both peak and off-peak seasons.

Ciprofloxacin Tablet 500mg, GMP Certificated,

Name: Ciprofloxacin Tablet 500mg, GMP Certificated,
Brand: JIANGXI XIERKANGTAI PHARMACEUTICAL CO., LTD.
SKU: 2057374405

Jiangxi, ChinaJIANGXI XIERKANGTAI PHARMACEUTICAL CO., LTD.

US$0.15

10,000 Pieces

Sample price:US$0.01/box.Request sample

Product profile

Customization

Available

Price

Low Price

Market

Africa

Model NO.

500MG

Properties

Tablet

Specifications

500mg

Transport Package

10*10/Box, 200boxes/Carton; 10's/Box

Specification

tablet

Trademark

OEM

Origin

China

HS Code

3004909099

Production Capacity

1000000box

Key features

GMP Certification: Manufactured under GMP standards ensuring high quality and safety.

Broad Spectrum Indications: Effective against infections in respiratory tract, ears, throat, abdomen, blood, bones, joints, skin, gall bladder, and eyes.

Anthrax Treatment Protocol: Recommended 50-day treatment course with 500mg dose every 12 hours for anthrax prevention and treatment.

OEM and ODM Services: Customization available from both samples and designs for tailored production needs.

100% Finished Product Inspection: All products undergo visual and functional inspection before shipment.

Established Manufacturer: Operating since 2004 with 21 years of export experience and 126 employees.

Flexible Payment Terms: Accepts T/T, D/P, PayPal, Western Union, and small-amount payments.

Global Shipping Options: Available via FOB, CIF, CFR, EXW from Shanghai, Guangzhou, and Ningbo ports.

Company profile

Years of Export ExperienceExhibition ExperienceStandardized quality controlFast Delivery

JIANGXI XIERKANGTAI PHARMACEUTICAL CO., LTD.

Jiangxi, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs CertifiedExport Year: 21 Years CertifiedNearest Port: Shanghai Port, Guangzhou Port, Ningbo PortAverage Response Time: ≤24h

AI-Powered supplier vetting

SummaryJIANGXI XIERKANGTAI PHARMACEUTICAL CO., LTD. is a China-based manufacturing factory established in 2004, with 126 employees and a combined business entity structure. Its stated scope covers pharmaceutical dosage forms, raw-material production and processing, and exports. The supplier reports customization from samples and designs, documented finished-product inspection, complaint handling, traceability, and quality-assurance procedures. It offers OEM services to well-known brands and has six R&D engineers, but reports no new products during the past year, no ODM service, and no SDK. Export sales account for 90% of total sales, with one-month stated lead times in both peak and off-season periods. Certification details are listed only as “Others,” and no cooperation with Fortune 500 companies is reported. Financial credibility cannot be assessed because the provided information does not include non-financial financial evidence.

Supplier typeThe supplier is identified as a factory and limited company in China, established on January 16, 2004, with 126 employees. Its stated business scope includes pharmaceutical production, processing, and export of raw materials, indicating a manufacturing-oriented supplier rather than a purely trading entity.

After-Sales capabilityThe supplier reports documented and followed procedures for handling customer complaints, service-capability assessment, corrective and preventive actions, and supplier management. However, the stated overseas-service coverage is 0 countries, so the evidence supports internal service processes but not broad overseas after-sales reach.

R&D capabilityThe supplier has six R&D engineers and provides OEM services to well-known brands. However, it reports no new products in the past year, no ODM service, and no available SDK, indicating that documented innovation and independent product-development capability are limited.

Production capacityThe supplier lists multiple pharmaceutical and equipment-related production capabilities, has a stated pharmaceutical manufacturing and processing scope, and reports uniformly followed finished-product inspection instructions. It also reports one-month average lead times in both peak and off-season periods, supporting evidence of established production operations.

Customization capabilityThe supplier explicitly supports customization from samples and from customer designs, and also reports OEM capability for well-known brands. Although it does not provide ODM services, the evidence directly supports customer-led customization and OEM production.

Product Q&A

Q:What infections does Ciprofloxacin 500mg treat?

It treats infections caused by susceptible germs in the respiratory tract, ears, throat, abdomen, blood, bones, joints, skin, gall bladder, and eyes, including anthrax.

Q:How should the tablet be taken?

Swallow the tablet whole with liquid, preferably two hours before or after meals. Do not chew.

Q:What is the dosage for adults?

The usual dose is 1 tablet every 12 hours. For acute infections, treatment lasts 5-10 days, continuing 3 days after symptoms disappear.

Q:Is dosage adjustment needed for liver or kidney issues?

No adjustment is needed for liver function. For disturbed renal function, the physician should adjust the prescription accordingly.

Q:What is the recommended dose for children?

For children aged 5-17, the dose is 20mg/kg every 12 hours, not exceeding 1500mg. For anthrax, it is 10-15mg/kg every 12 hours.